Gujarat Apollo: Q2 PAT falls 16% YoY on tax hit despite 55% revenue growth (adj. flat)
PAT -15.8% YoY · revenue +55% · margins compressing
₹19.98 Cr
+55% YoY
₹1.97 Cr
-15.8% YoY
7.44%
-3.9pp YoY
₹1.52
Gujarat Apollo Industries' consolidated revenue rose 55% year-on-year to ₹19.98 Cr (₹12.89 Cr in Q2 FY26), but consolidated net profit (₹1.5684 Cr reported PAT plus ₹0.4054 Cr share of associate profit) fell 16% YoY to ₹1.97 Cr from ₹2.34 Cr, with EPS at ₹1.52 against ₹1.98 a year ago. This is a micro-cap with no analyst coverage or formal consensus estimate (confirmed via search), so the print can only be judged against its own trend rather than street numbers, and management has put no public guidance or concall commentary on record, so there is no formal outlook bar to measure against either.
Q2 FY-2027 vs prior quarters
The profit decline did not come from the core business — operating performance actually improved YoY: EBITDA margin excluding other income (PBT + depreciation + finance costs − other income, as a % of revenue) narrowed to -6.1% this quarter from -18.2% a year ago and -34.5% last quarter, as higher volumes absorbed fixed costs better. The net-margin compression (NPM 7.4% vs 11.4% YoY) instead came from below the operating line: other income fell to ₹6.57 Cr from ₹7.74 Cr, finance costs rose to ₹1.11 Cr from ₹0.95 Cr, and this quarter alone carries a one-off ₹0.32 Cr prior-year tax adjustment. Stripping that one-off, adjusted PAT is roughly flat YoY (-2.4% vs -15.8% reported), so the underlying bottom line held up better than the headline suggests.
The stock went into the print at ₹339.85, up 2.1% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
Standalone PAT of just ₹0.14 Cr is a fraction of the ₹1.97 Cr consolidated figure — almost entirely a function of associate/subsidiary pickup and inter-corporate-deposit interest income consolidated at group level (consolidated other income ₹6.57 Cr vs standalone ₹3.11 Cr) — so the consolidated basis is the one to anchor on. The quarter sits alongside the company's ₹37.63 Cr divestment of its Credo Advanced Chemicals stake, announced October 6, 2026, after the September 30 quarter-end; neither the cash nor any gain from that sale is reflected in this print and will show up only from Q3 FY27.
W1
Whether the ₹37.63 Cr Credo Advanced Chemicals stake-sale proceeds (announced Oct 6, 2026) flow through Q3 FY27 other income or cash balance.
W2
Whether the operating EBITDA margin (-6.1% this quarter, from -34.5% in Q1 FY27) keeps narrowing toward positive as revenue scales, or reverses.
W3
Whether the ₹0.32 Cr one-off prior-year tax adjustment was a single-quarter event, since it understated this quarter's adjusted PAT growth relative to the reported number.
Consolidated PAT ₹1.9738 Cr = filing's 'Profit After Tax(5-6)' line ₹1.5684 Cr + ₹0.4054 Cr share of profit of associate (PFH Agri Equipment), added below the PAT line per the statement's own layout — this combined figure matches the reported EPS (₹1.52) and our DB's prior-quarter convention exactly. Current quarter also carries a one-off ₹0.3156 Cr prior-year tax adjustment absent in the comparative quarters. No exceptional items reported in either basis. Standalone PAT (₹0.14 Cr) is far below consolidated (₹1.97 Cr) — gap driven by subsidiary/associate pickup and ICD-interest income consolidated at group level.